Capricor Therapeutics, Inc.

CAPRNASDAQHealthcare● Active

$26.16

$-0.55(-2.06%)

Market Cap$1.2B

P/E Ratio—

52W High$40.37

52W Low$4.3

Avg Volume1.2M

Open$27.15

Beta0.37

Insider Trades Ownership Employees

Capricor Therapeutics, Inc. (CAPR) Insider Trading

Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.

SEC EDGAR · FMP · CAPR · as of Jun 8, 2026

Activity summary

Buy transactions

P-Purchase only

Sell transactions

12 Months

Buy/Sell ratio

0.00

Buy/Sell (by trades)

Overall sentiment

BEARISH

↑ Buy 0%Active transactions only · RSU vesting excluded100% Sell ↓

Capricor Therapeutics, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only

As of Jun 8, 2026

CAPR insider buying and selling by quarter

CAPR insider selling · CAPR insider buying stocks · quarterly insider activity

Total insider buying (incl. awards)Total insider selling

2.8M1.4M0

2024 Q1

2024 Q2

2024 Q3

2024 Q4

2025 Q1

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters

As of Jun 8, 2026

Active insiders

Most active in past 12 months · CAPR ceo insider trading

Showing all insiders · Click a card to filter the transactions table below

▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API

Recent insider transactions

CAPR executive sell shares · CAPR board member insider trading · CAPR insider trading SEC filing

Showing 31 most recent · Common Stock · Form 4 only

Scroll horizontally to see all columns

Date	Insider	Type	Shares	Price	Value	After trans.	Filing
May 18, 2026	Bergmann Anthony CHIEF FINANCIAL OFFICER	Option	3,000	$1.39	$4K	11,223	Form 4
May 13, 2026	Litvack Frank Director	Option	3,937	$1.39	$5K	133,776	Form 4
May 1, 2026	Krasney Karen EVP, GENERAL COUNSEL	Option	25,000	$3.18	$80K	55,547	Form 4
May 1, 2026	Krasney Karen EVP, GENERAL COUNSEL	Sale	25,000	$31.70	$793K	30,547	Form 4
May 1, 2026	Bergmann Anthony CHIEF FINANCIAL OFFICER	Option	25,000	$3.18	$80K	33,223	Form 4
May 1, 2026	Bergmann Anthony CHIEF FINANCIAL OFFICER	Sale	25,000	$31.70	$793K	8,223	Form 4
Apr 2, 2026	Sabar Karimah Es Director	Option	7,529	$3.18	$24K	7,529	Form 4
Apr 2, 2026	Sabar Karimah Es Director	Sale	7,529	$32.00	$241K	0	Form 4
Mar 31, 2026	Krasney Karen EVP, GENERAL COUNSEL	Option	2,819	$3.18	$9K	55,547	Form 4
Mar 31, 2026	Krasney Karen EVP, GENERAL COUNSEL	Option	21,488	$3.74	$80K	52,728	Form 4
Mar 31, 2026	Krasney Karen EVP, GENERAL COUNSEL	Option	693	$1.39	$963	31,240	Form 4
Mar 31, 2026	Krasney Karen EVP, GENERAL COUNSEL	Sale	25,000	$30.12	$753K	30,547	Form 4
Mar 31, 2026	Sabar Karimah Es Director	Option	61,265	$4.86	$298K	61,265	Form 4
Apr 1, 2026	Sabar Karimah Es Director	Option	53,735	$4.86	$261K	53,735	Form 4
Mar 31, 2026	Sabar Karimah Es Director	Sale	61,265	$30.17	$1.85M⚡	0	Form 4
Apr 1, 2026	Sabar Karimah Es Director	Sale	53,735	$31.03	$1.67M⚡	0	Form 4
Mar 31, 2026	Bergmann Anthony CHIEF FINANCIAL OFFICER	Option	25,000	$3.18	$80K	33,223	Form 4
Mar 31, 2026	Bergmann Anthony CHIEF FINANCIAL OFFICER	Sale	25,000	$30.13	$753K	8,223	Form 4
Dec 30, 2025	Krasney Karen EVP, GENERAL COUNSEL	Option	2,500	$1.39	$3K	30,547	Form 4
Dec 19, 2025	DUNBAR GEORGE W JR Director	Option	3,000	$1.39	$4K	14,306	Form 4
Mar 3, 2025	Marban Linda CHIEF EXECUTIVE OFFICER · Director	Option	25,000	$1.39	$35K	223,604	Form 4
Mar 5, 2025	Marban Linda CHIEF EXECUTIVE OFFICER · Director	Other	12,500	—	—	211,104	Form 4
Mar 3, 2025	Bergmann Anthony CHIEF FINANCIAL OFFICER	Option	2,500	$1.39	$3K	8,223	Form 4
Mar 3, 2025	Litvack Frank Director	Option	25,000	$1.39	$35K	132,382	Form 4
Mar 3, 2025	Litvack Frank Director	Other	2,543	$13.67	$35K	129,839	Form 4

Bergmann Anthony

CHIEF FINANCIAL OFFICER

Option

Date

May 18

3,000

Price

$1.39

Value

$4K

View Form 4 on SEC.gov

Litvack Frank

Director

Option

Date

May 13

3,937

Price

$1.39

Value

$5K

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Option

Date

May 1

25,000

Price

$3.18

Value

$80K

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Sale

Date

May 1

25,000

Price

$31.70

Value

$793K

View Form 4 on SEC.gov

Bergmann Anthony

CHIEF FINANCIAL OFFICER

Option

Date

May 1

25,000

Price

$3.18

Value

$80K

View Form 4 on SEC.gov

Bergmann Anthony

CHIEF FINANCIAL OFFICER

Sale

Date

May 1

25,000

Price

$31.70

Value

$793K

View Form 4 on SEC.gov

Sabar Karimah Es

Director

Option

Date

Apr 2

7,529

Price

$3.18

Value

$24K

View Form 4 on SEC.gov

Sabar Karimah Es

Director

Sale

Date

Apr 2

7,529

Price

$32.00

Value

$241K

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Option

Date

Mar 31

2,819

Price

$3.18

Value

$9K

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Option

Date

Mar 31

21,488

Price

$3.74

Value

$80K

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Option

Date

Mar 31

693

Price

$1.39

Value

$963

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Sale

Date

Mar 31

25,000

Price

$30.12

Value

$753K

View Form 4 on SEC.gov

Sabar Karimah Es

Director

Option

Date

Mar 31

61,265

Price

$4.86

Value

$298K

View Form 4 on SEC.gov

Sabar Karimah Es

Director

Option

Date

Apr 1

53,735

Price

$4.86

Value

$261K

View Form 4 on SEC.gov

Sabar Karimah Es

Director

Sale

Date

Mar 31

61,265

Price

$30.17

Value

$1.85M ⚡

View Form 4 on SEC.gov

Sabar Karimah Es

Director

Sale

Date

Apr 1

53,735

Price

$31.03

Value

$1.67M ⚡

View Form 4 on SEC.gov

Bergmann Anthony

CHIEF FINANCIAL OFFICER

Option

Date

Mar 31

25,000

Price

$3.18

Value

$80K

View Form 4 on SEC.gov

Bergmann Anthony

CHIEF FINANCIAL OFFICER

Sale

Date

Mar 31

25,000

Price

$30.13

Value

$753K

View Form 4 on SEC.gov

Krasney Karen

EVP, GENERAL COUNSEL

Option

Date

Dec 30

2,500

Price

$1.39

Value

$3K

View Form 4 on SEC.gov

DUNBAR GEORGE W JR

Director

Option

Date

Dec 19

3,000

Price

$1.39

Value

$4K

View Form 4 on SEC.gov

Marban Linda

CHIEF EXECUTIVE OFFICER · Director

Option

Date

Mar 3

25,000

Price

$1.39

Value

$35K

View Form 4 on SEC.gov

Marban Linda

CHIEF EXECUTIVE OFFICER · Director

Other

Date

Mar 5

12,500

Price

—

Value

—

View Form 4 on SEC.gov

Bergmann Anthony

CHIEF FINANCIAL OFFICER

Option

Date

Mar 3

2,500

Price

$1.39

Value

$3K

View Form 4 on SEC.gov

Litvack Frank

Director

Option

Date

Mar 3

25,000

Price

$1.39

Value

$35K

View Form 4 on SEC.gov

Litvack Frank

Director

Other

Date

Mar 3

2,543

Price

$13.67

Value

$35K

View Form 4 on SEC.gov

⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar

1 / 2

▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —

About CAPR insider trading

CAPR insider trades

Capricor Therapeutics, Inc. (CAPR) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Krasney Karen (EVP, GENERAL COUNSEL), Sabar Karimah Es (Director), Bergmann Anthony (CHIEF FINANCIAL OFFICER). Over the past 12 months, 5 insiders have filed transactions with the SEC. CAPR insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.

For Capricor Therapeutics, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →

Buy/Sell signal logic

acquisitionOrDisposition field:

A = Acquisition (buy) · D = Disposition (sell)

RSU vesting (M-Exempt) excluded from sentiment

Form 4SEC filing required within 2 business days of any insider transaction

10b5-1Pre-scheduled trading plan that allows insiders to sell on autopilot

Open MktDirect purchase or sale on the open market (excludes awards, options)

Ownership SEC filings Financial statements Price history Forecast & ratings Earnings

Frequently asked questions

CAPR insider trading · 5 questions

The insiders of Capricor Therapeutics, Inc. (CAPR) include executives and directors such as Krasney Karen (EVP, GENERAL COUNSEL), Sabar Karimah Es (Director), Bergmann Anthony (CHIEF FINANCIAL OFFICER), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.

CAPR board member insider tradingwho are CAPR insidersCAPR insider rosterCapricor Therapeutics, Inc. executives insider activity

▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026